PrognomiQ, a healthcare company focused on harnessing the power of proteomics and multi-omics data to transform the detection and early treatment selection and monitoring of cancer and other complex ...

At the Association for Molecular Pathology annual meeting in Boston, stakeholders discussed regulatory and legislative priorities for the coming year.

In this blog we will explore relevant issues pertaining to patients with complex corneas — irregular astigmatism, keratoconus, corneal trauma or post-corneal surgery — who represent approximately 12% ...